全球空間基因組學和轉錄組學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，空間基因組學和轉錄組學市場規模將達到 1,826,960,000 美元，高於 2025 年的 491,350,000 美元，預計從 2026 年到 2034 年的複合年成長率將達到 15.71%。

由於能夠分析組織空間背景下的基因表現，全球空間基因組學和轉錄組學市場正迅速發展。這項技術正在變革生物醫學研究，尤其是在腫瘤學、神經科學和免疫學領域。不斷成長的研究經費和人們對精準醫療日益濃厚的興趣，都推動了全球市場的強勁成長。

關鍵促進因素包括定序技術的進步、影像技術的改進以及對細胞層面疾病理解的日益成長的需求。製藥和生物技術公司正擴大採用空間分析工具進行藥物發現和生物標記鑑定。人工智慧 (AI) 和數據分析的融合進一步提升了空間基因組分析的準確性和價值。

隨著臨床應用的不斷拓展，該市場的未來前景依然十分光明。隨著技術的成本效益提高和標準化程度的提升，其應用預計將從實驗室擴展到臨床診斷領域。未來十年，研究機構和生技公司之間持續的創新與合作有望加速市場成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球空間基因體學與轉錄組學市場：按空間轉錄組學技術分類

• 市場分析、洞察與預測
• 空間轉錄組學
• 免疫組織化學（IHC）
• 螢光原位雜合反應（FISH）
• 定序
• 原位採集
• In Silico構建
• 基於顯微鏡的RNA成像技術
• 體內轉錄組分析 (TIVA)
• 空間基因組分析
• 基於螢光的定序
• 螢光顯微鏡
• 其他技術

第5章：全球空間基因體學與轉錄組學市場：依產品分類

• 市場分析、洞察與預測
• 消耗品
• 裝置
• 軟體
• 影像工具
• 生物資訊學工具
• 儲存和管理資料庫

第6章：全球空間基因體學與轉錄組學市場：按應用分類

• 市場分析、洞察與預測
• 轉化研究
• 藥物發現與開發

第7章 全球空間基因體學與轉錄組學市場：依最終使用者分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 受託研究機構
• 學術研究機構

第8章：全球空間基因體學和轉錄組學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Natera Inc
  • 10x Genomics
  • Dovetail Genomics
  • Illumina Inc
  • S2 Genomics Inc
  • NanoString Technologies Inc
  • Seven Bridges Genomics
  • Horizon Discovery Group Plc
  • Cartana AB
  • Readcoor Inc
  • Bio-Techne Corporation
  • Bio-Rad Laboratories Inc
  • Danahar Corporation
  • BioSpyder Technologies Inc
  • Lunaphore Technologies SA

The Spatial Genomics & Transcriptomics Market size is expected to reach USD 1826.96 Million in 2034 from USD 491.35 Million (2025) growing at a CAGR of 15.71% during 2026-2034.

The Global Spatial Genomics & Transcriptomics Market has gained rapid momentum due to its ability to analyze gene expression within the spatial context of tissues. This technology is transforming biomedical research, especially in oncology, neuroscience, and immunology. Increasing research funding and rising interest in precision medicine are contributing to strong market growth worldwide.

The key drivers include advancements in sequencing technologies, improved imaging techniques, and the growing need for better disease understanding at the cellular level. Pharmaceutical and biotechnology companies are increasingly adopting spatial analysis tools for drug discovery and biomarker identification. The integration of artificial intelligence and data analytics is further enhancing the accuracy and value of spatial genomic insights.

Future prospects for this market remain highly promising as clinical applications expand. As technology becomes more cost-effective and standardized, its adoption is expected to grow beyond research laboratories into clinical diagnostics. Continued innovation and collaboration between research institutions and biotech companies will likely accelerate market expansion over the next decade.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Spatial Transcriptomics Technique

• Spatial Transcriptomics
• Immunohistochemistry (IHC)
• Fluorescent In-situ Hybridization (FISH)
• Sequencing
• In-situ Capturing
• In-silico Construction
• Microscopy-based RNA Imaging Techniques
• Transcriptome In-vivo Analysis (TIVA)
• Spatial Genomics Analysis
• Fluorescence In-situ Sequencing
• Fluorescence Microscopy
• Other Techniques

By Product

• Consumables
• Instruments
• Software
• Imaging Tools
• Bioinformatics Tools
• Storage and Management Databases

By Application

• Translational Research
• Drug Discovery & Development

By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes

COMPANIES PROFILED

• Natera Inc, 10x Genomics, Dovetail Genomics, Illumina Inc, S2 Genomics Inc, NanoString Technologies Inc, Seven Bridges Genomics, Horizon Discovery Group plc, Cartana AB, Readcoor Inc, BioTechne Corporation, BioRad Laboratories Inc, Danahar Corporation, BioSpyder Technologies Inc, Lunaphore Technologies SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY SPATIAL TRANSCRIPTOMICS TECHNIQUE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Spatial Transcriptomics Technique
• 4.2. Spatial Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunohistochemistry (IHC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fluorescent In-situ Hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. In-situ Capturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. In-silico Construction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Microscopy-based RNA Imaging Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Transcriptome In-vivo Analysis (TIVA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Spatial Genomics Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Fluorescence In-situ Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Fluorescence Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.13. Other Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Imaging Tools Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinformatics Tools Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Storage and Management Databases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Translational Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Spatial Transcriptomics Technique
  • 8.2.2 By Product
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Spatial Transcriptomics Technique
  • 8.3.2 By Product
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Spatial Transcriptomics Technique
  • 8.4.2 By Product
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Spatial Transcriptomics Technique
  • 8.5.2 By Product
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Spatial Transcriptomics Technique
  • 8.6.2 By Product
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Natera Inc
  • 10.2.2 10x Genomics
  • 10.2.3 Dovetail Genomics
  • 10.2.4 Illumina Inc
  • 10.2.5 S2 Genomics Inc
  • 10.2.6 NanoString Technologies Inc
  • 10.2.7 Seven Bridges Genomics
  • 10.2.8 Horizon Discovery Group Plc
  • 10.2.9 Cartana AB
  • 10.2.10 Readcoor Inc
  • 10.2.11 Bio-Techne Corporation
  • 10.2.12 Bio-Rad Laboratories Inc
  • 10.2.13 Danahar Corporation
  • 10.2.14 BioSpyder Technologies Inc
  • 10.2.15 Lunaphore Technologies SA